Physician profile
Jamil Ahmed
NPI 1801830385
$2,874.92
in general payments reported to CMS, 2019-2025
14 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $218 · 2021: $184 · 2022: $274 · 2023: $360 · 2024: $1,016 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,089.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,667.79 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $432.33 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.28 | 2019-2025 | Ofev, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $63.98 | 2022-2025 | Glassia |
| Teva Pharmaceuticals USA, INC. | $57.01 | 2022 | |
| Merck Sharp & Dohme LLC | $52.27 | 2019-2024 | Winrevair |
| Insmed, INC. | $45.92 | 2025 | Arikayce |
| Baxter Healthcare | $41.57 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $37.95 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $32.42 | 2025 | Dupixent |
| Genzyme Corporation | $30.36 | 2025 | |
| United Therapeutics Corporation | $25.41 | 2024 | |
| Abbvie INC. | $16.84 | 2023 | Ubrelvy |
| Resmed Corp | $14.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamil Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.